Edesa Biotech: Funding, Investors & Team (Sep 2026)
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for dermatological and anorectal ailments. Their primary goal is to develop innovative and effective alternatives to steroids for conditions like Allergic Contact Dermatitis, Hemorrhoids, and Anal Fissures. The company's main product, EB01, is a groundbreaking non-steroidal anti-inflammatory molecule designed to treat allergic contact dermatitis. Numerous clinical studies have already shown significant improvements resulting from its use.
Edesa Biotech has raised $36.0M across 3 funding rounds on record, the most recent an undisclosed round of $2.5M announced in Jun 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Edesa Biotech Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Edesa Biotech Funding Rounds
Edesa Biotech raised $23.0M in an undisclosed round announced in Oct 2023.
1.3 years later, an undisclosed round of $10.5M was announced in Feb 2025.
1.3 years later, an undisclosed round of $2.5M was announced in Jun 2026.
Edesa Biotech Founders and Leadership Team
Contact details for the Edesa Biotech team: 2 of 2 have an email address on file.
Start 14-day free trial →Edesa Biotech Funding Compared to Other Biotechnology Startups
Edesa Biotech's latest round of $2.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Edesa Biotech in Biotechnology and Markham
Companies Similar to Edesa Biotech
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Resverlogix Corporation, a biopharmaceutical company, focuses on the development of novel therapeutics in…
Edesa Biotech Funding FAQs
What does Edesa Biotech do?
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for dermatological and anorectal ailments. Their primary goal is to develop innovative and effective alternatives to steroids for conditions like Allergic Contact Dermatitis, Hemorrhoids, and Anal Fissures. The company's main product, EB01, is a groundbreaking non-steroidal anti-inflammatory molecule designed to treat allergic contact dermatitis. Numerous clinical studies have already shown significant improvements resulting from its use.
How much funding has Edesa Biotech raised?
Edesa Biotech has raised $36.0M across 3 rounds on record. The most recent is an undisclosed round of $2.5M announced in Jun 2026.
When did Edesa Biotech last raise funding?
Edesa Biotech's most recent funding round on record is an undisclosed round of $2.5M, announced in Jun 2026.
Who founded Edesa Biotech?
FundedIQ lists Leo Bonifacio (Founder), Par Nijhawan (Founder) at Edesa Biotech.
Where is Edesa Biotech headquartered?
Edesa Biotech is based in Markham, Ontario, Canada.
How many employees does Edesa Biotech have?
Edesa Biotech is in the 11-50 employee band.
How does Edesa Biotech's funding compare to other Biotechnology startups?
Edesa Biotech's latest round of $2.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Edesa Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Edesa Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.